Healthcare -
Biotechnology - NASDAQ - CA
$ 3.78
8.62 %
$ 8.1 M
Market Cap
-0.04
P/E
APTO - COST OF REVENUE
Cost of Revenue APTO - Aptose Biosciences Inc.
475 K
LAST VALUE
-12.27%
2 YEAR CAGR
41.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR